Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 359674, 10 pages
http://dx.doi.org/10.1155/2013/359674
Research Article

STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV-1 Infection, and Inhibits IL-10+ Regulatory CD8+ T Cells in Autoimmune Uveitis

1Molecular Immunology Section, National Eye Institute, National Institutes of Allergy and Viral Diseases, National Institutes of Health, Building 10, Room 10N109A, 10 Center Drive, Bethesda, MD 20892-1857, USA
2Cellular Biology and Viral Immunology Section, National Institutes of Allergy and Viral Diseases, National Institutes of Health, Building 33, Room 2E13, 33 North Drive, Bethesda, MD, USA

Received 22 April 2013; Accepted 19 August 2013

Academic Editor: Hidde Bult

Copyright © 2013 Cheng-Rong Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Akira, Y. Nishio, M. Inoue et al., “Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway,” Cell, vol. 77, no. 1, pp. 63–71, 1994. View at Google Scholar · View at Scopus
  2. Z. Zhong, Z. Wen, and J. E. Darnell Jr., “Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6,” Science, vol. 264, no. 5155, pp. 95–98, 1994. View at Google Scholar · View at Scopus
  3. C. E. Egwuagu, “STAT3 in CD4+ T helper cell differentiation and inflammatory diseases,” Cytokine, vol. 47, no. 3, pp. 149–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Takeda, K. Noguchi, W. Shi et al., “Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 3801–3804, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kobayashi, M. N. Kweon, H. Kuwata et al., “Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice,” Journal of Clinical Investigation, vol. 111, no. 9, pp. 1297–1308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. J. Harris, J. F. Grosso, H. R. Yen et al., “Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity,” Journal of Immunology, vol. 179, no. 7, pp. 4313–4317, 2007. View at Google Scholar · View at Scopus
  7. X. Liu, Y. S. Lee, C. R. Yu, and C. E. Egwuagu, “Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases,” Journal of Immunology, vol. 180, no. 9, pp. 6070–6076, 2008. View at Google Scholar · View at Scopus
  8. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” The Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Takeda, T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira, “Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice,” Journal of Immunology, vol. 161, no. 9, pp. 4652–4660, 1998. View at Google Scholar · View at Scopus
  10. H. M. Oh, C. R. Yu, N. Golestaneh et al., “STAT3 promotes T-cell survival and inhibits IL-2 production through up-regulation of class O forkhead transcription factors,” The Journal of Biological Chemistry, vol. 286, no. 35, pp. 30888–30897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Decman, P. R. Kinchington, S. A. K. Harvey, and R. L. Hendricks, “Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression,” Journal of Virology, vol. 79, no. 16, pp. 10339–10347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. M. Oh, C. R. Yu, Y. Lee, C. C. Chan, A. Maminishkis, and C. E. Egwuagu, “Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms,” Journal of Immunology, vol. 187, no. 6, pp. 3338–3346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. R. Yu, H. M. Oh, N. Golestaneh et al., “Persistence of IL-2 expressing Th17 cells in healthy humans and experimental autoimmune uveitis,” European Journal of Immunology, vol. 41, no. 12, pp. 3495–3505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Oh, C. R. Yu, N. Golestaneh et al., “STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of class O forkhead transcription factors,” The Journal of Biological Chemistry, vol. 286, no. 35, pp. 30888–30897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. S. Lee, A. Amadi-Obi, C. R. Yu, and C. E. Egwuagu, “Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10,” Immunology, vol. 132, no. 4, pp. 492–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Zhang and M. J. Bevan, “CD8+ T cells: foot soldiers of the immune system,” Immunity, vol. 35, no. 2, pp. 161–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. J. Lee, S. C. Jameson, and K. A. Hogquist, “Alternative memory in the CD8 T cell lineage,” Trends in Immunology, vol. 32, no. 2, pp. 50–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Shrikant, R. Rao, Q. Li et al., “Regulating functional cell fates in CD8 T cells,” Immunologic Research, vol. 46, no. 1–3, pp. 12–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. R. Mosmann, L. Li, and S. Sad, “Functions of CD8 T-cell subsets secreting different cytokine patterns,” Seminars in Immunology, vol. 9, no. 2, pp. 87–92, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Tanigaki and T. Honjo, “Regulation of lymphocyte development by Notch signaling,” Nature Immunology, vol. 8, no. 5, pp. 451–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Tanigaki, M. Tsuji, N. Yamamoto et al., “Regulation of αβ/γδ T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling,” Immunity, vol. 20, no. 5, pp. 611–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Durant, W. T. Watford, H. L. Ramos et al., “Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis,” Immunity, vol. 32, no. 5, pp. 605–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Laurence and J. J. O'Shea, “TH-17 differentiation: of mice and men,” Nature Immunology, vol. 8, no. 9, pp. 903–905, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Laurence, C. M. Tato, T. S. Davidson et al., “Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation,” Immunity, vol. 26, no. 3, pp. 371–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. McGeachy, Y. Chen, C. M. Tato et al., “The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo,” Nature Immunology, vol. 10, no. 3, pp. 314–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Oh, C. R. Yu, I. Dambuza, B. Marrero, and C. E. Egwuagu, “STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4+ T cells,” The Journal of Biological Chemistry, vol. 287, no. 36, pp. 30436–30443, 2012. View at Publisher · View at Google Scholar
  27. K. S. Frederiksen, D. Lundsgaard, J. A. Freeman et al., “IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma,” Cancer Immunology, Immunotherapy, vol. 57, no. 10, pp. 1439–1449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. Frank, A. J. Lepisto, M. L. Freeman, B. S. Sheridan, T. L. Cherpes, and R. L. Hendricks, “Early CD4+ T cell help prevents partial CD8+ T cell exhaustion and promotes maintenance of herpes simplex virus 1 latency,” Journal of Immunology, vol. 184, no. 1, pp. 277–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Thimme, V. Appay, M. Koschella et al., “Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation,” Journal of Virology, vol. 79, no. 18, pp. 12112–12116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Amadi-Obi, C. R. Yu, X. Liu et al., “T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1,” Nature Medicine, vol. 13, no. 6, pp. 711–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. H. Lee, Y. Ishida, M. Rifa'i, Z. Shi, K. Isobe, and H. Suzuki, “Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 180, no. 2, pp. 825–832, 2008. View at Google Scholar · View at Scopus
  32. R. R. Caspi, “Ocular autoimmunity: the price of privilege?” Immunological Reviews, vol. 213, no. 1, pp. 23–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. C. R. Yu, Y. S. Lee, R. M. Mahdi, N. Surendran, and C. E. Egwuagu, “Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis,” PLoS ONE, vol. 7, no. 1, Article ID e29742, 2012. View at Publisher · View at Google Scholar · View at Scopus